In the next two decades the number of diabetes cases around the world is expected to increase by 50 percent. The rise means that a staggering amount of people are at risk of severe health conditions, including blindness. The National Institutes of Health (NIH) awarded a $2.8 million grant to the Translational Genomics Research Institute (TGen) to aid in the discovery of new treatments for diabetic blindness.


“We hope our findings will result in a diagnostic for early prediction of disease severity, development of new biomarkers, and improved therapeutic targets that may prevent the progression of diabetic retinopathy,” said Dr. Sampath Rangasamy, Ph.D., Research Assistant Professor in TGen’s Neurogenomics Division, and the study’s Principal Investigator at TGen.

SDCB can help improve your life quality with the help of our innovative programs. Please contact us to learn more.

“$2.8M TGen grant will address diabetic blindness”